COVID-19 Adversely Affecting Patients With Genitourinary Cancers
In an online survey, 17.2% of patients with genitourinary cancers reported they delayed or avoided seeking medical care because of the COVID-19 pandemic.
In an online survey, 17.2% of patients with genitourinary cancers reported they delayed or avoided seeking medical care because of the COVID-19 pandemic.
Investigators say inequities in the social determinants of health likely explain the racial and ethnic disparities.
A cancer center in New York City safely managed patients with localized prostate cancer during the height of the COVID-19 pandemic in 2020, providing insights for handling a second COVID-19 wave.
56.4% of cancer survivors report having one or more conditions, with increased prevalence in Black survivors
Dialysis facilities would be more successful at immunizing patients against the COVID-19 coronavirus if they receive direct allocations of the vaccine, according to officials from major dialysis companies.
Moderate positive correlation seen between OHSD and percentage of positive antibody tests to SARS-CoV-2 in NYC neighborhoods
In addition, starting this week, states are receiving 5 percent more vaccine doses
Adjusted excess all-cause mortality was 6.8 per 10,000 for Blacks and 1.5 per 10,000 for Whites, with considerable variation across states
In a recent cohort study, the risk for COVID-19 infection did not differ significantly between ADT users and nonusers.
In a study of patients hospitalized with COVID-19 complicated by acute kidney injury requiring kidney replacement therapy, almost two-thirds of discharged patients had full recovery of kidney function.